Singulex, Inc., is a leader in advanced biomarker research, deploying
high precision, high sensitivity, digital immunoassay technology to enable
groundbreaking discovery, innovative therapies and improved healthcare.
The Erenna Immunoassay System, powered by Singulex's patented single-molecule
detection technology, accurately, precisely and reliably quantifies
low-abundance biomarkers at or below sub-picogram concentrations. This unique
high-definition technology enhances the clinical utility of biomarkers and
allows researchers to gain insights into drug safety and efficacy.
- Quantifying the Previously Undetectable
- Uncovering Novel Biology
- Accelerating Discovery
- Generating Relevant Data
- Requiring Fewer Data Points for Critical Decision Making
- Reducing Program Costs & Improving ROI
Click on the following bullet points for more details about our Erenna
technology, products, and services.
Unless otherwise noted, Singulex products are for research use only and not intended for diagnostics use.